Showing results (491-500 of 542) with videos related to
Sort By:
Pageof 55
Neurodegenerative Disease Management|July 25, 2018
Psychometric properties of apathy scales in Parkinson's disease: a systematic reviewDana Mohammad, Courtney Ellis, Allison Rau, et al.Neurodegenerative Disease Management|July 26, 2018
Cardiovascular function is related to neuromuscular performance in Parkinson's diseaseMahmoud A Alomari, Hanan Khalil, Omar F Khabour, et al.Neurodegenerative Disease Management|September 8, 2016
Clinical pharmacology review of opicapone for the treatment of Parkinson's diseaseMargherita Fabbri, Mario M Rosa, Joaquim J FerreiraNeurodegenerative Disease Management|September 8, 2016
A consensus initiative for the assessment of patients newly diagnosed with multiple sclerosis in Spain: the eXamina ProjectVirginia Meca-Lallana, Rafael Arroyo-González, José Meca-Lallana, et al.Neurodegenerative Disease Management|September 8, 2016
Elucidating the link between the modifiable risk factors of Alzheimer's disease and neuroinflammationStephanie M Schindler, Andis KlegerisNeurodegenerative Disease Management|April 24, 2018
Palatability and oral cavity tolerability of THC:CBD oromucosal spray and possible improvement measures in multiple sclerosis patients with resistant spasticity: a pilot studyGiacomo Lus, Roberto Cantello, Maura Chiara Danni, et al.Neurodegenerative Disease Management|May 17, 2014
Depression versus dementia: is this construct still relevant?Zahinoor Ismail, Arfeen Malick, Eric E Smith, et al.Neurodegenerative Disease Management|May 17, 2014
What are the priorities in Parkinson's disease clinical research? A focus on motor complications, gait and cognitionAlison J YarnallNeurodegenerative Disease Management|May 17, 2014
Is neuropsychological rehabilitation effective in multiple sclerosis?Päivi Hämäläinen, Eija Rosti-OtajärviNeurodegenerative Disease Management|May 17, 2014
The impact of multiple sclerosis on family members: a review of the literatureMichele Messmer UccelliPageof 55